We are live on ! Find out more
CO

Global Cord Blood Corporation
CO

Delisted

CO was delisted on the 23rd of September, 2022.

Back to rankings

37 hedge funds and large institutions have $31.6M invested in Global Cord Blood Corporation in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

28% more funds holding

Funds holding: 29 → 37 (+8)

13% more capital invested

Capital invested by funds: $28M → $31.6M (+$3.56M)

46% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 13

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
37
Holders Change
+8
Holders Change %
+27.59%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
7
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$2.41M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.26M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.21M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$1.13M
5
GCP
GSA Capital Partners
United Kingdom
+$915K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.98M
2
MYAM
Meiji Yasuda Asset Management
Japan
-$930K
3
EMR
Errol M. Rudman
-$878K
4
AR
Advisory Research
Illinois
-$219K
5
RCM
Rotella Capital Management
Washington
-$172K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
26
Virtu KCG Holdings
New York
$106K -$32.8K -5,350 -24%
STMM
27
South Texas Money Management
Texas
$90K -$54.9K -8,945 -38%
Invesco
28
Invesco
Georgia
$89K -$9.98K -1,626 -10%
TC
29
TFS Capital
Pennsylvania
$89K +$88.7K +14,453 New
Verition Fund Management
30
Verition Fund Management
Connecticut
$79K +$78.4K +12,779 New
PPA
31
Parametric Portfolio Associates
Washington
$68K -$10.5K -1,715 -13%
RCM
32
Rotella Capital Management
Washington
$64K -$172K -28,100 -73%
FNYS
33
First New York Securities
New York
$40K +$39.9K +6,500 New
UBS Group
34
UBS Group
Switzerland
$19K -$1.85K -302 -9%
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$6K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$6K +$4.61K +751 +250%
Wells Fargo
37
Wells Fargo
California
$1K – – –
CCM
38
Cortex Capital Management
Texas
– -$3.42M -668,215 Closed
MYAM
39
Meiji Yasuda Asset Management
Japan
– -$930K -181,900 Closed
EMR
40
Errol M. Rudman
– -$878K -171,741 Closed
Creative Planning
41
Creative Planning
Kansas
– -$26K -5,000 Closed
1
2

CO Hedge Fund Activity: Q2 2015 in Review

37 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2015, worth a combined $31.6M — up 13% from $28M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CO positions and 4 closed out — a net gain of 8 holders — while 7 added to existing stakes and 13 trimmed.

The largest buyer was Citigroup, adding an estimated $2.41M. The largest seller was Fidelity Investments, cutting an estimated $7.98M.

  • 37 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2015, up from 29 in Q1 2015.
  • Funds reported $31.6M of Global Cord Blood Corporation stock for Q2 2015, up 13% quarter-over-quarter.
  • 12 funds opened new Global Cord Blood Corporation positions in Q2 2015 and 4 closed out, a net change of +8 holders.
  • The largest Global Cord Blood Corporation buyer in Q2 2015 was Citigroup, an estimated $2.41M added.
  • The largest Global Cord Blood Corporation seller in Q2 2015 was Fidelity Investments, an estimated $7.98M sold.

Based on aggregated 13F filings for Q2 2015.